A new target

Retail investors in Asia and Australia have snapped up a wide array of structured credit products over the past two years. And now these products are starting to emerge in Europe’s traditionally equity-focused structured products market. By Patrick Fletcher

credit-risk-coverstory-gif

Ask retail investors in Europe for a definition of ‘structured products’ and at some point they will probably mention capital-guaranteed notes, most likely referencing one of the half a dozen world equity indexes. Ask the same question in Asia and you may well get an answer that involves structured credit.

Over the past two years, retail investors in Australia, New Zealand, Hong Kong and Taiwan have snapped up an array of credit derivatives structures, from credit-linked notes to synthetic

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here